INFI Annual Cash & Cash Equivalents
$38.31 M
-$42.41 M-52.54%
31 December 2022
Summary:
As of January 21, 2025, INFI annual cash & cash equivalents is $38.31 million, with the most recent change of -$42.41 million (-52.54%) on December 31, 2022. During the last 3 years, it has risen by +$16.05 million (+72.12%).INFI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Quarterly Cash And Cash Equivalents
$17.75 M
-$7.99 M-31.05%
30 June 2023
Summary:
As of January 21, 2025, INFI quarterly cash and cash equivalents is $17.75 million, with the most recent change of -$7.99 million (-31.05%) on June 30, 2023. Over the past year, it has dropped by -$28.09 million (-61.29%).INFI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.5% | -61.3% |
| 3 y3 years | +72.1% | -38.6% |
| 5 y5 years | +10.7% | -63.9% |
INFI Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -87.5% | -94.5% |
Infinity Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $17.75 M(-31.0%) |
| Mar 2023 | - | $25.74 M(-32.8%) |
| Dec 2022 | $38.31 M(-52.5%) | $38.31 M(-18.8%) |
| Sept 2022 | - | $47.18 M(+2.9%) |
| June 2022 | - | $45.84 M(-13.7%) |
| Mar 2022 | - | $53.13 M(-34.2%) |
| Dec 2021 | $80.73 M(+182.3%) | $80.73 M(-10.4%) |
| Sept 2021 | - | $90.09 M(-7.4%) |
| June 2021 | - | $97.26 M(-8.9%) |
| Mar 2021 | - | $106.76 M(+273.4%) |
| Dec 2020 | $28.59 M(+28.5%) | $28.59 M(+54.3%) |
| Sept 2020 | - | $18.53 M(-35.9%) |
| June 2020 | - | $28.92 M(-5.1%) |
| Mar 2020 | - | $30.48 M(+36.9%) |
| Dec 2019 | $22.26 M(-54.2%) | $22.26 M(+3.1%) |
| Sept 2019 | - | $21.59 M(-49.4%) |
| June 2019 | - | $42.63 M(-19.5%) |
| Mar 2019 | - | $52.95 M(+8.9%) |
| Dec 2018 | $48.62 M(+40.5%) | $48.62 M(+50.9%) |
| Sept 2018 | - | $32.22 M(-34.5%) |
| June 2018 | - | $49.16 M(+60.8%) |
| Mar 2018 | - | $30.57 M(-11.7%) |
| Dec 2017 | $34.61 M(-53.3%) | $34.61 M(+3.1%) |
| Sept 2017 | - | $33.58 M(-49.3%) |
| June 2017 | - | $66.20 M(-12.2%) |
| Mar 2017 | - | $75.43 M(+1.8%) |
| Dec 2016 | $74.06 M(-60.6%) | $74.06 M(-24.8%) |
| Sept 2016 | - | $98.51 M(-19.5%) |
| June 2016 | - | $122.35 M(+7.6%) |
| Mar 2016 | - | $113.75 M(-39.5%) |
| Dec 2015 | $188.17 M(-38.8%) | $188.17 M(+37.1%) |
| Sept 2015 | - | $137.28 M(+2.0%) |
| June 2015 | - | $134.61 M(-39.7%) |
| Mar 2015 | - | $223.04 M(-27.4%) |
| Dec 2014 | $307.40 M(+351.3%) | $307.40 M(-4.3%) |
| Sept 2014 | - | $321.26 M(+275.7%) |
| June 2014 | - | $85.52 M(+55.6%) |
| Mar 2014 | - | $54.97 M(-19.3%) |
| Dec 2013 | $68.11 M(-61.2%) | $68.11 M(+27.4%) |
| Sept 2013 | - | $53.48 M(-3.2%) |
| June 2013 | - | $55.25 M(-45.4%) |
| Mar 2013 | - | $101.14 M(-42.4%) |
| Dec 2012 | $175.74 M(+626.3%) | $175.74 M(+232.1%) |
| Sept 2012 | - | $52.92 M(+169.3%) |
| June 2012 | - | $19.65 M(-16.2%) |
| Mar 2012 | - | $23.46 M(-3.0%) |
| Dec 2011 | $24.20 M | $24.20 M(+4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $23.09 M(+32.2%) |
| June 2011 | - | $17.46 M(-19.6%) |
| Mar 2011 | - | $21.72 M(+6.4%) |
| Dec 2010 | $20.42 M(+25.4%) | $20.42 M(+12.3%) |
| Sept 2010 | - | $18.18 M(-25.6%) |
| June 2010 | - | $24.44 M(+46.8%) |
| Mar 2010 | - | $16.65 M(+2.2%) |
| Dec 2009 | $16.29 M(-1.7%) | $16.29 M(-52.1%) |
| Sept 2009 | - | $33.97 M(+86.1%) |
| June 2009 | - | $18.26 M(+29.5%) |
| Mar 2009 | - | $14.10 M(-14.9%) |
| Dec 2008 | $16.57 M(-28.4%) | $16.57 M(-11.9%) |
| Sept 2008 | - | $18.82 M(+148.5%) |
| June 2008 | - | $7.57 M(-71.1%) |
| Mar 2008 | - | $26.21 M(+13.1%) |
| Dec 2007 | $23.16 M(-68.8%) | $23.16 M(+26.8%) |
| Sept 2007 | - | $18.27 M(+9.0%) |
| June 2007 | - | $16.75 M(-36.3%) |
| Mar 2007 | - | $26.31 M(-64.5%) |
| Dec 2006 | $74.15 M(+685.2%) | $74.15 M(-16.7%) |
| Sept 2006 | - | $88.98 M(+246.9%) |
| June 2006 | - | $25.65 M(+2.1%) |
| Mar 2006 | - | $25.12 M(+166.0%) |
| Dec 2005 | $9.44 M(-28.2%) | $9.44 M(-72.5%) |
| Sept 2005 | - | $34.38 M(+18.9%) |
| June 2005 | - | $28.92 M(-18.9%) |
| Mar 2005 | - | $35.66 M(+171.2%) |
| Dec 2004 | $13.15 M(+67.6%) | $13.15 M(+87.1%) |
| Sept 2004 | - | $7.03 M(+3.6%) |
| June 2004 | - | $6.78 M(+18.0%) |
| Mar 2004 | - | $5.75 M(-26.7%) |
| Dec 2003 | $7.85 M(-5.6%) | $7.85 M(+142.3%) |
| Sept 2003 | - | $3.24 M(-33.5%) |
| June 2003 | - | $4.87 M(-28.8%) |
| Mar 2003 | - | $6.84 M(-17.7%) |
| Dec 2002 | $8.31 M(-83.7%) | $8.31 M(-21.3%) |
| Sept 2002 | - | $10.56 M(-63.3%) |
| June 2002 | - | $28.78 M(-40.9%) |
| Mar 2002 | - | $48.73 M(-4.3%) |
| Dec 2001 | $50.92 M(-47.9%) | $50.92 M(-0.2%) |
| Sept 2001 | - | $50.99 M(-22.1%) |
| June 2001 | - | $65.48 M(-19.0%) |
| Mar 2001 | - | $80.82 M(-17.3%) |
| Dec 2000 | $97.69 M(+3286.6%) | $97.69 M(+0.5%) |
| Sept 2000 | - | $97.21 M(+2575.4%) |
| June 2000 | - | $3.63 M(+269.3%) |
| Mar 2000 | - | $983.80 K |
| Dec 1999 | $2.88 M | - |
FAQ
- What is Infinity Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Infinity Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Infinity Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of INFI is $38.31 M
What is the all time high annual cash & cash equivalents for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high annual cash & cash equivalents is $307.40 M
What is Infinity Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, INFI annual cash & cash equivalents has changed by -$42.41 M (-52.54%)
What is Infinity Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of INFI is $17.75 M
What is the all time high quarterly cash and cash equivalents for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high quarterly cash and cash equivalents is $321.26 M
What is Infinity Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, INFI quarterly cash and cash equivalents has changed by -$28.09 M (-61.29%)